310 related articles for article (PubMed ID: 24371144)
1. The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression.
Liu Y; Sánchez-Tilló E; Lu X; Huang L; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC
J Biol Chem; 2014 Feb; 289(7):4116-25. PubMed ID: 24371144
[TBL] [Abstract][Full Text] [Related]
2. Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression.
Liu Y; Sánchez-Tilló E; Lu X; Huang L; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC
J Biol Chem; 2013 Apr; 288(16):11572-80. PubMed ID: 23443660
[TBL] [Abstract][Full Text] [Related]
3. An Rb1-dependent amplification loop between Ets1 and Zeb1 is evident in thymocyte differentiation and invasive lung adenocarcinoma.
Dean KC; Huang L; Chen Y; Lu X; Liu Y
BMC Mol Biol; 2015 Mar; 16():8. PubMed ID: 25880398
[TBL] [Abstract][Full Text] [Related]
4. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
Wellner U; Schubert J; Burk UC; Schmalhofer O; Zhu F; Sonntag A; Waldvogel B; Vannier C; Darling D; zur Hausen A; Brunton VG; Morton J; Sansom O; Schüler J; Stemmler MP; Herzberger C; Hopt U; Keck T; Brabletz S; Brabletz T
Nat Cell Biol; 2009 Dec; 11(12):1487-95. PubMed ID: 19935649
[TBL] [Abstract][Full Text] [Related]
5. Rb1 family mutation is sufficient for sarcoma initiation.
Liu Y; Sánchez-Tilló E; Lu X; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC
Nat Commun; 2013; 4():2650. PubMed ID: 24150016
[TBL] [Abstract][Full Text] [Related]
6. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
[TBL] [Abstract][Full Text] [Related]
7. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
8. A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster.
Li XL; Hara T; Choi Y; Subramanian M; Francis P; Bilke S; Walker RL; Pineda M; Zhu Y; Yang Y; Luo J; Wakefield LM; Brabletz T; Park BH; Sharma S; Chowdhury D; Meltzer PS; Lal A
Mol Cell Biol; 2014 Feb; 34(3):533-50. PubMed ID: 24277930
[TBL] [Abstract][Full Text] [Related]
9. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
[TBL] [Abstract][Full Text] [Related]
10. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.
Xi S; Xu H; Shan J; Tao Y; Hong JA; Inchauste S; Zhang M; Kunst TF; Mercedes L; Schrump DS
J Clin Invest; 2013 Mar; 123(3):1241-61. PubMed ID: 23426183
[TBL] [Abstract][Full Text] [Related]
12. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.
Burk U; Schubert J; Wellner U; Schmalhofer O; Vincan E; Spaderna S; Brabletz T
EMBO Rep; 2008 Jun; 9(6):582-9. PubMed ID: 18483486
[TBL] [Abstract][Full Text] [Related]
13. Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis.
Liu Y; Lu X; Huang L; Wang W; Jiang G; Dean KC; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Darling DS; Postigo A; Dean DC
Nat Commun; 2014 Dec; 5():5660. PubMed ID: 25434817
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.
Cieply B; Farris J; Denvir J; Ford HL; Frisch SM
Cancer Res; 2013 Oct; 73(20):6299-309. PubMed ID: 23943797
[TBL] [Abstract][Full Text] [Related]
15. Isocitrate dehydrogenase (IDH) mutations promote a reversible ZEB1/microRNA (miR)-200-dependent epithelial-mesenchymal transition (EMT).
Grassian AR; Lin F; Barrett R; Liu Y; Jiang W; Korpal M; Astley H; Gitterman D; Henley T; Howes R; Levell J; Korn JM; Pagliarini R
J Biol Chem; 2012 Dec; 287(50):42180-94. PubMed ID: 23038259
[TBL] [Abstract][Full Text] [Related]
16. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
[TBL] [Abstract][Full Text] [Related]
17. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT.
Al-Khalaf HH; Aboussekhra A
J Biol Chem; 2014 Nov; 289(45):31433-47. PubMed ID: 25261470
[TBL] [Abstract][Full Text] [Related]
19. The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5.
Sundararajan V; Gengenbacher N; Stemmler MP; Kleemann JA; Brabletz T; Brabletz S
Oncotarget; 2015 Sep; 6(29):27083-96. PubMed ID: 26334100
[TBL] [Abstract][Full Text] [Related]
20. MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells.
Kharbanda A; Rajabi H; Jin C; Alam M; Wong KK; Kufe D
Oncotarget; 2014 Oct; 5(19):8893-905. PubMed ID: 25245423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]